Friday, July 11, 2014 Last update: 3:33 AM
FreshNews.com - All Company Technology News Since 1996

Marina Biotech, Inc.

News articles for Marina Biotech, Inc.:

Thursday, June 12, 2014

Thursday, June 5, 2014

Wednesday, May 28, 2014

  • Marina Biotech to Present at the LD Micro Invitational 2014
    BOSTON, MA -- (Marketwired) -- 05/28/14 -- Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today announced that J. Michael French, President and CEO, will present at the LD Micro Invitational 2014 on Wednesday, June 4th, 2014 at the ... read more

Wednesday, May 14, 2014

  • Marina Biotech Provides Organizational Update
    BOSTON, MA -- (Marketwired) -- 05/14/14 -- Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today provided an organizational update that include naming Daniel Geffken, M.B.A. as interim Chief Financial Officer and the engagement of Wolf & Co., P.C. ... read more

Tuesday, May 6, 2014

Tuesday, March 11, 2014

Thursday, February 27, 2014

Monday, February 24, 2014

Thursday, January 23, 2014

Tuesday, January 14, 2014

Thursday, January 9, 2014

Friday, January 3, 2014

  • Marina Biotech Announces Organizational Changes
    BOSTON, MA -- (Marketwired) -- 01/03/14 -- Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading oligonucleotide-based drug discovery and development company, announced today that Philip C. Ranker will join the Marina Biotech Board of Directors and that Richard T. Ho, M.D., Ph.D., will become the Chair of the Marina Biotech ... read more

Wednesday, August 14, 2013

Monday, May 13, 2013

Thursday, December 6, 2012

  • Marina Biotech, Inc. Announces Year-to-Date 2012 Financial Results
    BOTHELL, WA -- (Marketwire) -- 12/06/12 -- Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading RNAi-based drug discovery and development company, yesterday reported financial results for the nine months ended September 30, 2012, and provided an update on 2012 corporate accomplishments. "We continue to rebuild the company, and improve shareholder ... read more

Wednesday, December 5, 2012

Tuesday, December 4, 2012

Thursday, October 11, 2012

  • Marina Biotech, Inc. Announces Full Year 2011 Financial Results
    BOTHELL, WA -- (Marketwire) -- 10/11/12 -- Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading RNAi-based drug discovery and development company, today reported financial results for the fiscal year ended December 31, 2011, and provided an update on recent corporate accomplishments and strategic direction. "The past nine months have been an ... read more

Wednesday, August 22, 2012

  • Marina Biotech Provides Update on Company Operations
    BOTHELL, WA -- (Marketwire) -- 08/22/12 -- Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading nucleic acid-based drug discovery and development company, today provided an update on its operations. The Company continues to seek adequate funding to implement its business plan and has accomplished the following in order to generate ... read more

Friday, August 3, 2012